Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
A Visually Interpretable Histopathology-Based Immune Model Predicts T-effector Biology and Response to Immune checkpoint inhibition in Clear Cell Renal Cell Carcinoma Clinical Trial and Contemporary Real-World Datasets.
Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026
Pediatric fibromuscular dysplasia presenting with acute right lower extremity limb ischemia requiring endovascular treatment and amputation - a case report.
Journal: BMC pediatrics
Published: February 17, 2026
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
Journal: Cancer cell
Published: February 01, 2026
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 09, 2026
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy.
Journal: medRxiv : the preprint server for health sciences
Published: December 03, 2025
Surveillance Alone After a Subtotal Resection of Disseminated Juvenile Xanthogranuloma.
Journal: Pediatric blood & cancer
Published: September 19, 2025
Histological features of liver biopsy in patients with COVID-19: a single institution experience with long term follow-up outcome.
Journal: Diagnostic pathology
Published: June 29, 2025
MorphoITH: a framework for deconvolving intra-tumor heterogeneity using tissue morphology.
Journal: Genome medicine
Published: February 21, 2025
Pelvic Mass in a Pediatric Patient: A Rare Case of Extraosseous Ewing Sarcoma.
Journal: Urology
Published: January 02, 2025
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors.
Journal: Acta neuropathologica communications
Published: July 18, 2024
Last Updated: 09/26/2026